Works matching IS 0008543X AND DT 2019 AND VI 125 AND IP 10


Results: 35
    1
    2
    3

    Errata.

    Published in:
    2019
    Publication type:
    corrected article
    4

    The e13a2 BCR‐ABL transcript negatively affects sustained deep molecular response and the achievement of treatment‐free remission in patients with chronic myeloid leukemia who receive tyrosine kinase inhibitors.

    Published in:
    Cancer (0008543X), 2019, v. 125, n. 10, p. 1674, doi. 10.1002/cncr.31977
    By:
    • D'Adda, Mariella;
    • Farina, Mirko;
    • Schieppati, Francesca;
    • Borlenghi, Erika;
    • Bottelli, Chiara;
    • Cerqui, Elisa;
    • Ferrari, Samantha;
    • Gramegna, Doriana;
    • Pagani, Chiara;
    • Passi, Angela;
    • Maifredi, Adriana;
    • Tucci, Alessandra;
    • Capucci, Maria A.;
    • Ruggeri, Giuseppina;
    • Rossi, Giuseppe
    Publication type:
    Article
    5

    Oral arsenic trioxide incorporation into frontline treatment with all-trans retinoic acid and chemotherapy in newly diagnosed acute promyelocytic leukemia: A 5-year prospective study.

    Published in:
    2019
    By:
    • Gill, Harinder;
    • Kumana, Cyrus R;
    • Yim, Rita;
    • Hwang, Yu-Yan;
    • Chan, Thomas S Y;
    • Yip, Sze-Fai;
    • Lee, Harold K K;
    • Mak, Vivien;
    • Lau, June S M;
    • Chan, Chi-Chung;
    • Kho, Bonnie;
    • Wong, Raymond S M;
    • Li, Wa;
    • Lin, Shek-Yin;
    • Lau, Chi-Kuen;
    • Ip, Ho-Wan;
    • Leung, Rock Y Y;
    • Lam, Clarence C K;
    • Kwong, Yok-Lam
    Publication type:
    journal article
    6
    7
    8
    9
    10
    11
    12
    13
    14
    16
    19
    20
    21
    22
    23
    24

    Errata.

    Published in:
    2019
    Publication type:
    corrected article
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35